Aug. 28 at 11:21 PM
$ADTX Aditxt owns 100% of Ignite Proteomics, a subsidiary that signed a definitive business combination agreement with Copley Acquisition Corp., valuing Ignite at
$150 million (
$10-per-share reference price).
The Bullish Trigger: The deal successfully closes by its targeted late-September 2026 window, raising up to
$30 million in fresh financing. Ignite spins off onto the NYSE as an independent entity.
The ADTX Impact: As the parent company, Aditxt retains a massive equity stake in a newly liquid, publicly traded
$150M asset. This instantly wipes out Aditxt’s historical stockholders' equity deficit on paper, overnight transforming its balance sheet from distressed to asset-rich.
Buying frenzy on Monday.
$SPY $QQQ $NVDA $TSLA
